Administration costs of intravenous biologic drugs for rheumatoid arthritis

SpringerPlus

Table 5 Results of the literature review: the average administration costs (€2011)*

Drug^a	Disease	N	Administration cost (€)	Range (€)	S.D. (€)
IFX	Rheumatoid arthritis	7	193.92	76.87–270.23	55.33
RTX	Rheumatoid arthritis	4	172.00	76.87–212.79	55.26
ABA	Rheumatoid arthritis	6	158.75	76.87–212.79	45.44
IFX	Crohn’s disease	4	276.58	163.08–484.57	129.31
IFX	Psoriatic arthritis, psoriasis	4	247.88	108.02–484.57	141.98
IFX	Ulcerative colitis	1	163.08	163.08–163.08	NS
RTX	Follicular (non-Hodgkin’s) lymphoma	2	165.02	99.06–230.97	65.96

* Costs from previous article publications were converted to Finnish purchasing power and reported in year 2011 value. N = number of observations. S.D. = standard deviation. IFX = infliximab. RTX = rituximab. ABA = abatacept. NS = not stated. ^a No administration costs for tocilizumab were found.